Blauvelt A, Langley RG, Peris K, Silvestre JF, Katoh N, Tauber M, Pinter A, Ameen M, Gooderham M, Øland CB, Tindberg A-M, Gjerum L, Reich K. Continuous Tralokinumab Treatment over 4 Years in Adults with Moderate-to-Severe Atopic Dermatitis Provides Long-Term Disease Control. J of Skin [Internet]. 2024Mar.18 [cited 2024Sep.20];8(2):s376. Available from: https://dermsquared.com/skin/article/view/2679